Literature DB >> 14313906

NEISSERIA CATARRHALIS BACTEREMIA WITH MENINGITIS.

L E PFISTER, M V GALLAGHER, T G POTTERFIELD, D W BROWN.   

Abstract

Keywords:  BACTERIOLOGICAL TECHNICS; BLOOD; CEREBROSPINAL FLUID; CHILD; CHLORAMPHENICOL; DRUG THERAPY; MENINGITIS; NEISSERIA; PENICILLIN; PHARYNX; SEPTICEMIA; SULFISOXAZOLE

Mesh：

Substances：

Year:  1965        PMID： 14313906     DOI： 10.1001/jama.1965.03090050075029

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors:  R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal:  Drugs       Date:  1986       Impact factor: 9.546

2.  In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

Authors:  S Alvarez; M Jones; S Holtsclaw-Berk; J Guarderas; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 3.  The pathogenic potential of commensal species of Neisseria.

Authors:  A P Johnson
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

Review 4.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Branhamella catarrhalis septicaemia in a granulocytopenic patient.

Authors:  F C Henny; C J Mulder; A S Lampe; J W van der Meer
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.